Placement of CS/LV Pacing Leads With EnSite NavX Guidance

Early Phase 1

Withdrawn

• Conditions: Heart Failure

• Registration Number: NCT00577187
• Lead Sponsor: Abbott Medical Devices

Brief Summary

This study utilizes the 3D mapping capabilities of the EnSite NavX mapping system to help guide the placement of the left ventricular lead during cardiovascular resynchronization therapy implant procedures with the goal of reducing fluoroscopic exposure and procedure time.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2007-12-18
• Study First Submitted QC: 2007-12-18
• Study First Posted: 2007-12-20
• Study Start: 2008-06
• Primary Completion: 2008-12
• Study Completion: 2008-12
• Status Verified: 2019-02
• Last Update Submitted: 2019-02-01
• Last Update Posted: 2019-02-04

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Patients schedule to undergo CRT implant (per established guidelines)

Exclusion Criteria

• Standard exclusions to CRT implant procedures

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Fluoroscopy and procedure time	Procedural

Trial Locations

Locations (1)

University of Nebraska Medical Center; 🇺🇸 Omaha, Nebraska, United States